Skip to main content
ALLR logo
ALLR
(NASDAQ)
Allarity Therapeutics, Inc.
$1.55-- (--)
Loading... - Market loading

Allarity Therapeutics (ALLR) Stock Price & Financial Analysis

Allarity Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.57 - $1.66
52-Week High$2.35
52-Week Low$0.77
Open$1.60
Volume169.14K
Average Volume (3M)249.95K
Market Cap21.42M
Shares Outstanding14.38M
Price to Sales (P/S)33.48
Price to Book (P/B)2.18
EV/EBITDA-0.60
Revenue (TTM)640.00K
Net Income (TTM)-11.87M
Free Cash Flow (TTM)-557.00K
EPS (TTM)$-0.78
Profit Margin-1855.00%
Operating Margin-1951.09%
Return on Equity (ROE)-120.80%
Debt to Equity0.14
50-Day MA$1.43
200-Day MA$1.30
52-Week Change75.52%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Allarity Therapeutics

What is the current stock price for ALLR?

As of the latest trading session, ALLR stock trades at $1.61. The 52-week range is $0.77–$2.35, with a day range of $1.57–$1.66.

What is the P/E ratio for ALLR?

The P/E ratio (Price-to-Earnings) for ALLR is shown in the Key Statistics section. This valuation metric helps compare Allarity Therapeutics, Inc. to industry peers.

Does ALLR pay dividends?

Allarity Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ALLR?

Based on 1 analyst, the consensus for ALLR is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ALLR?

Allarity Therapeutics's market capitalization is $23.2M, classifying it as a micro-cap company. Allarity Therapeutics operates in the Healthcare sector within the Biotechnology industry.